
-
Ex-Premier League star Li Tie loses appeal in 20-year bribery sentence
-
Belgium's green light for red light workers
-
Haliburton leads comeback as Pacers advance, Celtics clinch
-
Rahm out to break 2025 win drought ahead of US PGA Championship
-
Japan tariff envoy departs for round two of US talks
-
Djurgarden eyeing Chelsea upset in historic Conference League semi-final
-
Haliburton leads comeback as Pacers advance, Pistons stay alive
-
Bunker-cafe on Korean border paints image of peace
-
Tunics & turbans: Afghan students don Taliban-imposed uniforms
-
Asian markets struggle as trade war hits China factory activity
-
Norwegian success story: Bodo/Glimt's historic run to a European semi-final
-
Spurs attempt to grasp Europa League lifeline to save dismal season
-
Thawing permafrost dots Siberia with rash of mounds
-
S. Korea prosecutors raid ex-president's house over shaman probe: Yonhap
-
Filipino cardinal, the 'Asian Francis', is papal contender
-
Samsung Electronics posts 22% jump in Q1 net profit
-
Pietro Parolin, career diplomat leading race to be pope
-
Nuclear submarine deal lurks below surface of Australian election
-
China's manufacturing shrinks in April as trade war bites
-
Financial markets may be the last guardrail on Trump
-
Swedish journalist's trial opens in Turkey
-
Kiss says 'honour of a lifetime' to coach Wallabies at home World Cup
-
US growth figure expected to make for tough reading for Trump
-
Opposition leader confirmed winner of Trinidad elections
-
Snedeker, Ogilvy to skipper Presidents Cup teams: PGA Tour
-
Win or bust in Europa League for Amorim's Man Utd
-
Trump celebrates 100 days in office with campaign-style rally
-
Top Cuban dissidents detained after court revokes parole
-
Arteta urges Arsenal to deliver 'special' fightback against PSG
-
Trump fires Kamala Harris's husband from Holocaust board
-
Pakistan says India planning strike as tensions soar over Kashmir attack
-
Weinstein sex attack accuser tells court he 'humiliated' her
-
France accuses Russian military intelligence over cyberattacks
-
Global stocks mostly rise as Trump grants auto tariff relief
-
Grand Vietnam parade 50 years after the fall of Saigon
-
Trump fires ex first gentleman Emhoff from Holocaust board
-
PSG 'not getting carried away' despite holding edge against Arsenal
-
Cuban dissidents detained after court revokes parole
-
Sweden stunned by new deadly gun attack
-
BRICS blast 'resurgence of protectionism' in Trump era
-
Trump tempers auto tariffs, winning cautious praise from industry
-
'Cruel measure': Dominican crackdown on Haitian hospitals
-
'It's only half-time': Defiant Raya says Arsenal can overturn PSG deficit
-
Dembele sinks Arsenal as PSG seize edge in Champions League semi-final
-
Les Kiss to take over Wallabies coach role from mid-2026
-
Real Madrid's Rudiger, Mendy and Alaba out injured until end of season
-
US threatens to quit Russia-Ukraine effort unless 'concrete proposals'
-
Meta releases standalone AI app, competing with ChatGPT
-
Zverev crashes as Swiatek scrapes into Madrid Open quarter-finals
-
BRICS members blast rise of 'trade protectionism'

Bayer says legal woes could force it to pull weedkiller
German chemicals giant Bayer said Friday it could be forced to pull its Roundup weedkiller from the market if it is not able to limit simmering legal troubles.
"We're nearing a point where the litigation industry could force us to even stop selling this vital product," CEO Bill Anderson said at Bayer's annual general meeting.
The Leverkusen-based group has said that after rumbling on for years, it has the aim of "significantly containing litigation by the end of 2026".
"The status quo is not an option," said Anderson, while the stakes for the chemicals and pharmaceuticals producer were "really high".
Bayer has been dogged by lawsuits linked to Roundup since it acquired the US manufacturer Monsanto in a blockbuster deal in 2018.
Claimants have alleged that glyphosate, the active ingredient in Roundup, causes blood cancers but Bayer says scientific studies and regulatory approvals show that the weedkiller is safe.
Bayer has battled to draw a line under Roundup litigation, spending more than $10 billion (8.8 billion euros) to date to settle suits alleging that Bayer failed to disclose health risks.
Earlier this month, Bayer said it would launch another appeal to the US Supreme Court to rule on the Roundup case, its third such attempt.
After being twice rebuffed by the court, Bayer is hopeful of more success following rulings by federal appellate courts, which the German group said support its case.
The renewed request for the Supreme Court to intervene is the first since Anderson took the reins at the chemicals group in 2023.
But Anderson's late arrival has not insulated the American manager from the criticism of shareholders, who voiced their impatience at the meeting.
Bayer has asked investors to approve a capital increase through the issuance of new stock to cover potential legal costs related to Roundup.
Shareholders were being asked to "pay the price" for Roundup's issues, Deka Investment manager Ingo Speich said, describing the move as a "bitter pill to swallow".
"Why should everything be different this time and the wave of lawsuits stopped with more money?", Janne Werning of Union Investment said.
C.Kreuzer--VB